The real-life findings showed that treatment with brodalumab improved health-related quality of life (HRQOL) for patients but itching prevented complete improvement. Despite achieving clear or almost ...

Higher disease acceptance in patients with psoriasis is linked to better outcomes, underscoring the need for psychological resilience in treatment. The study found illness acceptance negatively ...

More than eight million people in the United States have the autoimmune skin condition known as psoriasis, according to the National Psoriasis Foundation. Psoriasis is a chronic condition. There’s no ...

If you’ve ever suffered from common skin conditions like rosacea, eczema or psoriasis, you know how uncomfortable the intense itching, dryness and redness can be. Fortunately, you don’t have to ...

Please provide your email address to receive an email when new articles are posted on . Arcutis Biotherapeutics announced positive results from two pivotal phase 3 studies evaluating Zoryve cream as a ...

Please provide your email address to receive an email when new articles are posted on . Increased joint pain and itch was significantly linked to an increase in overall fatigue. Disease severity was ...

For most people, psoriasis causes red, itchy, and scaly patches on the skin. But for some, the tight, dry, and inflamed lesions can also cause pain in the skin. One study found that pain was ...

DENVER — The topical TrkA kinase inhibitor CT327 reduces chronic itch in patients with psoriasis, according to results from a new study. "This is an unmet need," said Gil Yosipovitch, MD, professor of ...

When we scratch an itch, something tells our brain when to stop. The post Science figures out why we know when to stop ...

Researchers identify the TRPV4 ion channel as the body's internal "stop scratching" signal, offering new hope for chronic itch relief.